
Biocept BIOC
Quarterly report 2023-Q2
added 08-14-2023
Biocept Total Inventories 2011-2026 | BIOC
Annual Total Inventories Biocept
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 757 K | 2.65 M | 1.93 M | 768 K | 587 K | 499 K | 549 K | 349 K | 189 K | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.65 M | 189 K | 920 K |
Quarterly Total Inventories Biocept
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 551 K | 704 K | 757 K | 1.9 M | 2.25 M | 3.22 M | 2.65 M | 2.9 M | 3.02 M | 3.26 M | 1.93 M | 1.93 M | 1.93 M | 1.93 M | 768 K | 768 K | 768 K | 768 K | 587 K | 587 K | 587 K | 587 K | 499 K | 499 K | 499 K | 499 K | 549 K | 549 K | 549 K | 549 K | 349 K | 349 K | 349 K | 349 K | 189 K | 189 K | 189 K | 189 K | 92.8 K | 92.8 K | 92.8 K | 92.8 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.26 M | 92.8 K | 978 K |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Co-Diagnostics
CODX
|
992 K | $ 1.29 | -20.86 % | $ 1.72 M | ||
|
Agilent Technologies
A
|
830 M | $ 111.67 | -1.39 % | $ 33.9 B | ||
|
Castle Biosciences
CSTL
|
10.3 M | $ 19.22 | 1.8 % | $ 557 M | ||
|
Aspira Women's Health
AWH
|
256 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | ||
|
Illumina
ILMN
|
547 M | $ 141.26 | -1.38 % | $ 22.5 B | ||
|
Interpace Biosciences
IDXG
|
1.11 M | $ 1.8 | - | $ 7.96 M | ||
|
CareDx, Inc
CDNA
|
26.7 M | $ 19.81 | -3.34 % | $ 1.06 B | ||
|
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | ||
|
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
64.7 M | $ 93.52 | -3.26 % | $ 6.31 B | ||
|
Mettler-Toledo International
MTD
|
387 M | $ 1 039.9 | -0.19 % | $ 21.4 B | ||
|
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M | ||
|
Myriad Genetics
MYGN
|
30.6 M | $ 3.61 | -0.41 % | $ 334 M | ||
|
NeoGenomics
NEO
|
28.6 M | $ 8.28 | -0.96 % | $ 1.06 B | ||
|
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | ||
|
Natera
NTRA
|
35.4 M | $ 188.14 | -4.45 % | $ 18.5 B | ||
|
Charles River Laboratories International
CRL
|
299 M | $ 154.29 | -3.04 % | $ 7.65 B | ||
|
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
166 M | - | - | $ 19.8 B | ||
|
Guardant Health
GH
|
85.9 M | $ 94.56 | -4.16 % | $ 11.9 B | ||
|
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
2.3 M | $ 117.67 | 0.5 % | $ 9.71 B | ||
|
Senseonics Holdings
SENS
|
6.7 M | $ 5.7 | -2.06 % | $ 238 M | ||
|
Soleno Therapeutics
SLNO
|
15 M | $ 52.99 | - | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
302 M | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
1.49 M | $ 2.36 | -2.07 % | $ 5.42 M | ||
|
Laboratory Corporation of America Holdings
LH
|
535 M | $ 251.95 | -0.81 % | $ 21 B | ||
|
Thermo Fisher Scientific
TMO
|
5.42 B | $ 439.75 | -1.87 % | $ 166 B | ||
|
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K | ||
|
Twist Bioscience Corporation
TWST
|
28.3 M | $ 48.67 | -8.08 % | $ 2.91 B | ||
|
Neogen Corporation
NEOG
|
191 M | $ 8.22 | -2.49 % | $ 1.78 B | ||
|
Quest Diagnostics Incorporated
DGX
|
189 M | $ 187.17 | -0.41 % | $ 20.8 B | ||
|
Invitae Corporation
NVTA
|
30.4 M | - | - | $ 21.2 M |